Table 4.
Patients with AE (n = 9) | Patients without AE (n = 61) | p-value | |
---|---|---|---|
Age (y) | 64.4 ± 8.9 | 65.3 ± 11.5 | .82 |
sex (f/m) | 4/5 | 36 /25 | .41 |
KPS Pre (%) | 80 [80–90] | 80 [80–90] | .99 |
KPS Post (%) | 80 [30–80] | 90 [80–90] | <.01 |
RPA | 2 [2–2] | 2 [2–2] | 1 |
Total BM (n) | 1.4 ± 0.7 | 1.7 ± 1.1 | .51 |
BM size (cm3) | 2.5 ± 0.9 | 3.3 ± 1.3 | .08 |
Applicator size (cm3) | 2.1 ± 0.5 | 2.4 ± 0.7 | .29 |
RT Dose (Gy) | 2 [1.5–2.5] | 2.5 [2–3] | .91 |
LOS (min) | 157 ± 72 | 154 ± 39 | .84 |
LORT (min) | 10 ± 4 | 10 ± 4 | .61 |
LOH (d) | 12 ± 8 | 7 ± 3 | <.001 |